Dow Chemical Seeks U.S. High Court Review On Patents Under Teva
WASHINGTON, D.C. — Dow Chemical Co. petitioned the U.S. Supreme Court on March 16 to determine under Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (135 S.Ct. 831 [2105]) whether appellate courts...To view the full article, register now.
Already a subscriber? Click here to view full article